European journal of obstetrics, gynecology, and reproductive biology · 2025
The influence of serum luteinising hormone concentrations post GnRH agonist trigger on metaphase II oocytes in IVF/ICSI cycles.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sawant Shital, Tulsyan Sasha, Homburg Roy
Аннотация
BACKGROUND: Gonadotropin-releasing hormone agonist (GnRHa) trigger is widely used in IVF/ICSI to reduce ovarian hyperstimulation syndrome (OHSS) risk, particularly in women with polycystic ovary syndrome (PCOS). However, the endocrine response is variable, and a threshold post-trigger luteinizing hormone (LH) level predictive of mature oocyte (metaphase II, MII) yield has not been clearly established. This study aimed to identify optimum and minimum LH levels measured 12 h after GnRHa trigger that are predictive of mature oocyte yield in PCOS patients.
METHODS: This prospective, single-centre observational study included 104 PCOS patients undergoing controlled ovarian stimulation with a GnRH antagonist protocol. Final oocyte maturation was triggered with 2 ml Buserelin. Serum LH, FSH, and progesterone were measured 12 h post-trigger. The primary outcome was the correlation between hormone levels and MII oocyte yield.
RESULTS: Mean LH at 12 h post-trigger was 34.05 IU/L (SD 23.07, range 0.9-134.4 IU/L). No significant correlation was found between LH and MII yield (r = -0.123; p = 0.215), fertilisation rate (r = 0.046; p = 0.641), or blastocyst formation (r = 0.162; p = 0.101). FSH and progesterone also showed no significant associations. ROC analysis showed poor predictive value of LH for mature oocyte yield (AUC = 0.402). MII yields varied widely across LH levels, with no identifiable minimum or optimum threshold.
CONCLUSION: No LH threshold at 12 h post-GnRHa trigger predicted optimal or suboptimal oocyte maturation. Routine post-trigger LH measurement lacks clinical utility for predicting mature oocyte yield in PCOS IVF/ICSI cycles.
METHODS: This prospective, single-centre observational study included 104 PCOS patients undergoing controlled ovarian stimulation with a GnRH antagonist protocol. Final oocyte maturation was triggered with 2 ml Buserelin. Serum LH, FSH, and progesterone were measured 12 h post-trigger. The primary outcome was the correlation between hormone levels and MII oocyte yield.
RESULTS: Mean LH at 12 h post-trigger was 34.05 IU/L (SD 23.07, range 0.9-134.4 IU/L). No significant correlation was found between LH and MII yield (r = -0.123; p = 0.215), fertilisation rate (r = 0.046; p = 0.641), or blastocyst formation (r = 0.162; p = 0.101). FSH and progesterone also showed no significant associations. ROC analysis showed poor predictive value of LH for mature oocyte yield (AUC = 0.402). MII yields varied widely across LH levels, with no identifiable minimum or optimum threshold.
CONCLUSION: No LH threshold at 12 h post-GnRHa trigger predicted optimal or suboptimal oocyte maturation. Routine post-trigger LH measurement lacks clinical utility for predicting mature oocyte yield in PCOS IVF/ICSI cycles.